4D Molecular Therapeutics, Inc. Class of Warrant or Right, Exercise Price of Warrants or Rights
4D Molecular Therapeutics, Inc. (FDMT) had Class of Warrant or Right, Exercise Price of Warrants or Rights of $9.41 per share as of 2021-04-30, per its 10-K filed 2024-02-29.
Financial Statements › Notes
us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 · last filed 2026-08-13
- 2021-04-30: Class of Warrant or Right, Exercise Price of Warrants or Rights $9.41.
- 2020-12-31: Class of Warrant or Right, Exercise Price of Warrants or Rights $18.00.
- 2018-05-31: Class of Warrant or Right, Exercise Price of Warrants or Rights $3.19.
- 2016-12-31: Class of Warrant or Right, Exercise Price of Warrants or Rights $1.14.
| Period end | Class of Warrant or Right, Exercise Price of Warrants or Rights |
|---|---|
| 2021-04-30 | $9.41 10-K · filed 2024-02-29 |
| 2020-12-31 | $18.00 10-Q · filed 2026-08-13 |
| 2018-05-31 | $3.19 10-Q · filed 2026-08-13 |
| 2016-12-31 | $1.14 10-K · filed 2024-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Entera Bio Ltd. (ENTX) | $0.485B |